🚨 A pivotal patent case is quietly signaling the next phase of competition in oncologyand the real winners may not be the ones you expect.
On its surface, Exelixis, Inc. v. Handa Pharmaceuticals Inc. looks like another day at the patent courthouse. …

Takeda vs. Sun Pharma: The Quiet Patent Battle That Can Move Entire Drug Prices
In the patent world, the loud fights grab headlines. The quiet oneswhere a few claims, a few dates, and a few eligibility arguments can determine years of exclusivityoften …

Azurity just lit up the patent debate landscapethis time with implications that go well beyond one case caption.
At first glance, Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Limited reads like another entry in the ongoing chess match between bran…

Vertex vs. Squires: When IP Strategy Meets Access and Reality
Most legal battles in biotech are decided in the fine printclaims construction, prior art, expert declarations, and procedural timing. But every so often, a dispute spills beyond the court…

The real question isnt whether a brand patent will get challenged. Its whether it will crumble.
If youre in pharmabrand-side, investor-side, or anything touching the litigation-to-revenue pipelineyou already know PTAB isnt a sideshow. For years, Patent…

Short answer: Yesmost clinicians recommend checking liver‑function tests (LFTs) before starting simvastatin (Lipitor)… https://www.Drugchatter.com/chat/30440/is-liver-function-monitoring-necessary-with-lipitor/

📌 Hot take: The next wave in tech patent battles isnt just about algorithmsits about devices, timing, and who controls the testing record.
A recent decision in Dish Technologies, LLC v. MW Media, S.C. is a reminder that in modern patent litigation…